INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ICU Medical, Inc. - ICUINEW YORK, May 18, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of ICU Medical, Inc. (“ICU” or the “Company”) (
NASDAQ: ICUI). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.
Bragar Eagel & Squire, P.C. Is Investigating Organon, Aldeyra, Landstar, and ICU Medical and Encourages Investors to Contact the FirmNEW YORK, May 14, 2025 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Organon & Co. (
NYSE:OGN), Aldeyra Therapeutics, Inc. (
NASDAQ:ALDX), Landstar System, Inc. (
NASDAQ:LSTR), and ICU Medical, Inc. (
NASDAQ: ICUI). Our investigations concern whether these companies have violated the federal securities laws and/or engaged in other unlawful business practices. Additional information about each case can be found at the link provided.
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of ICU Medical, Inc. – ICUINEW YORK, May 13, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of ICU Medical, Inc. (“ICU” or the “Company”) (
NASDAQ: ICUI). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.
Solventum, Envista, ICU Medical, Globus Medical, and Enovis Stocks Trade Up, What You Need To KnowA number of stocks jumped in the afternoon session after the major indices popped (Nasdaq +3.4%, S&P 500 +2.5%) in response to the positive outcome of U.S.-China trade negotiations, as both sides agreed to pause some tariffs for 90 days, signaling a potential turning point in ongoing tensions. This rollback cuts U.S. tariffs on Chinese goods to 30% and Chinese tariffs on U.S. imports to 10%, giving companies breathing room to reset inventories and supply chains.
ICUI Q1 Earnings Call: Product Upgrades and Tariff Headwinds Shape OutlookMedical device company ICU Medical (
NASDAQ:ICUI) reported Q1 CY2025 results topping the market’s revenue expectations, with sales up 5.8% year on year to $599.5 million. Its non-GAAP profit of $1.72 per share was 34.4% above analysts’ consensus estimates.
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ICU Medical, Inc. - ICUINEW YORK, May 09, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of ICU Medical, Inc. (“ICU” or the “Company”) (
NASDAQ: ICUI). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.
1 Small-Cap Stock to Target This Week and 2 to Keep Off Your RadarInvestors looking for hidden gems should keep an eye on small-cap stocks because they’re frequently overlooked by Wall Street.
Many opportunities exist in this part of the market, but it is also a high-risk, high-reward environment due to the lack of reliable analyst price targets.
ICU Medical (NASDAQ:ICUI) Delivers Impressive Q1Medical device company ICU Medical (
NASDAQ:ICUI) reported Q1 CY2025 results beating Wall Street’s revenue expectations, with sales up 6.7% year on year to $604.7 million. Its non-GAAP profit of $1.72 per share was 34.4% above analysts’ consensus estimates.
ICU Medical Announces First Quarter 2025 ResultsSAN CLEMENTE, Calif., May 08, 2025 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced financial results for the quarterly period ended March 31, 2025.
Bragar Eagel & Squire, P.C. Is Investigating RobinHood, Aldeyra, Landstar, and ICU Medical and Encourages Investors to Contact the FirmNEW YORK, May 07, 2025 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against RobinHood Markets, Inc. (
NASDAQ: HOOD), Aldeyra Therapeutics, Inc. (
NASDAQ:ALDX), Landstar System, Inc. (
NASDAQ:LSTR), and ICU Medical, Inc. (
NASDAQ: ICUI). Our investigations concern whether these companies have violated the federal securities laws and/or engaged in other unlawful business practices. Additional information about each case can be found at the link provided.
What To Expect From ICU Medical’s (ICUI) Q1 EarningsMedical device company ICU Medical (
NASDAQ:ICUI)
will be announcing earnings results tomorrow after the bell. Here’s what you need to know.
ICU MEDICAL SECURITIES INVESTIGATION: Kaplan Fox & Kilsheimer LLP is Investigating ICU Medical, Inc. (ICUI) for Possible Securities Law ViolationsNEW YORK - May 5, 2025 (NEWMEDIAWIRE) - Kaplan Fox & Kilsheimer LLP is investigating potential securities violations against ICU Medical, Inc. (“ICU Medical” or the “Company”) (
NASDAQ: ICUI).
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of ICU Medical, Inc. – ICUINEW YORK, May 05, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of ICU Medical, Inc. (“ICU” or the “Company”) (
NASDAQ: ICUI). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.
ICUI SHAREHOLDER ALERT: Kaplan Fox & Kilsheimer LLP is Investigating ICU Medical, Inc. (ICUI) for Potential Securities Law ViolationsSearch for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
ICUI SHAREHOLDER ALERT: Kaplan Fox & Kilsheimer LLP is Investigating ICU Medical, Inc. (ICUI) for Potential Securities Law ViolationsNEW YORK, NY - May 3, 2025 (NEWMEDIAWIRE) - Kaplan Fox & Kilsheimer LLP is investigating potential securities violations against ICU Medical, Inc. (“ICU Medical” or the “Company”) (
NASDAQ: ICUI).
ICU MEDICAL ALERT: Kaplan Fox & Kilsheimer LLP is Investigating ICU Medical, Inc. (ICUI) for Potential Securities Law ViolationsSearch for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
ICU MEDICAL ALERT: Kaplan Fox & Kilsheimer LLP is Investigating ICU Medical, Inc. (ICUI) for Potential Securities Law ViolationsNEW YORK, NY - May 1, 2025 (NEWMEDIAWIRE) - Kaplan Fox & Kilsheimer LLP is investigating potential securities violations against ICU Medical, Inc. (“ICU Medical” or the “Company”) (
NASDAQ: ICUI).
ICU MEDICAL Investors Are Encouraged to Contact Kaplan Fox & Kilsheimer LLP Regarding Potential Securities Law ViolationsSearch for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
ICU MEDICAL Investors Are Encouraged to Contact Kaplan Fox & Kilsheimer LLP Regarding Potential Securities Law ViolationsNEW YORK, NY - April 30, 2025 (NEWMEDIAWIRE) - Kaplan Fox & Kilsheimer LLP is investigating potential securities violations against ICU Medical, Inc. (“ICU Medical” or the “Company”) (
NASDAQ: ICUI).
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ICU Medical, Inc. - ICUINEW YORK, April 29, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of ICU Medical, Inc. (“ICU” or the “Company”) (
NASDAQ: ICUI). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.
ICU MEDICAL Is Being Investigated for Potential Securities Law Violations Contact Kaplan Fox & Kilsheimer LLPNEW YORK, NY - April 28, 2025 (NEWMEDIAWIRE) - Kaplan Fox & Kilsheimer LLP is investigating potential securities violations against ICU Medical, Inc. (“ICU Medical” or the “Company”) (
NASDAQ: ICUI).
ICU MEDICAL Is Being Investigated for Potential Securities Law Violations Contact Kaplan Fox & Kilsheimer LLPSearch for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Kaplan Fox & Kilsheimer LLP is Investigating Potential Securities Law Violations Against ICU Medical, Inc. (ICUI)Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.